0001209191-21-007884.txt : 20210204 0001209191-21-007884.hdr.sgml : 20210204 20210204184753 ACCESSION NUMBER: 0001209191-21-007884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210202 FILED AS OF DATE: 20210204 DATE AS OF CHANGE: 20210204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TEVANIAN AVADIS CENTRAL INDEX KEY: 0001214091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 21592690 MAIL ADDRESS: STREET 1: DOLBY LABORATORIES INC STREET 2: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0927 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-02 0 0001308547 Dolby Laboratories, Inc. DLB 0001214091 TEVANIAN AVADIS C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 1 0 0 0 Class A Common Stock 2021-02-02 4 A 0 2661 0.00 A 2661 D Class A Common Stock 2021-02-02 4 S 0 1814 90.00 D 50561 I By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996 Award represents a total of 2,661 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2022 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. Shares held following the reported transactions include 2,661 restricted stock units, which are subject to forfeiture until they vest. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. /s/ Daniel Rodriguez, as Attorney-in-Fact for Avadis Tevanian 2021-02-04